A Prospective, Longitudinal, Case Control, Observational Study of Cerebral Venous Sinus Thrombosis in Western Maharashtra, India. Risk Factors, Clinical Presentations and Complications. - CVST

Pfizer Limited0 个研究点目标入组 250 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Males and females between 18 and 65 years of age.
•2.Cerebral venous thrombosis confirmed by cerebral angiography (with intra-arterial contrast injection) or magnetic resonance venography or computed tomographic venography.
•3.Patients or authorized representative must be able and willing to provide written informed consent.
•4.Patients who are willing to or likely to comply with all study requirements.
•Inclusion for Control Arm Subjects
•1.Age and gender matched healthy individuals from
•community or hospital patients with minor illnesses from general OPD without any neurological conditions or previous history of thrombosis or CVST who is willing to participate.
•2.Males and females between 18 and 65 years of age.
•3.Patients or authorized representative must be able and
•willing to provide written informed consent.
•4.Patients who are willing to or likely to comply with all study
•requirements.

•1.Any known associated condition (such as cancer) with a poor short term (1 year) (terminal illness) prognosis independent of CVST.
•2.Recent ( < 2 weeks) major surgical procedure including head & brain surgery (does not include lumbar puncture) or severe cranial trauma.
•3.Patients who are unlikely to comply with protocol requirements (e.g., non-cooperative behavior, inability to attend the protocol visits).
•4.Patients who are currently participating or had participated in other interventional study for last 30 days prior to their enrollment.

发起方